Lv11
30 积分 2024-10-20 加入
Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study
27分钟前
已完结
The immunoproteasome disturbs neuronal metabolism and drives neurodegeneration in multiple sclerosis
38分钟前
已完结
Progressive multiple sclerosis: Six trials to watch
59分钟前
求助中
皖公网安备34019202002308
